Please assess the completion status of the following clinical trial:

Trial Title: Eye Movements and Reading Disabilities

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* 1. Age 7 to 13 (Must be in at least 2nd grade, but not higher than 8th grade) 2. Complete ophthalmic examination performed by a pediatric ophthalmologist and orthoptist.~  3. All ocular structures must be within normal limits. 4. Best corrected visual acuity must be equal to or better than 20/30 in each eye.~  5. Group 1:~ 1. Children with a reading disability must be given the diagnosis by a clinical educational specialist, educational psychologist or neuro-behavioral psychologist.~ 2. Children with a reading disability may not have any ophthalmic anomaly determined by testing as described above. This includes but is not limited to amblyopia, strabismus, nystagmus, or any organic disease.~     6. Group 2~  a. Eye movement disorder confirmed by testing by a pediatric ophthalmologist and/or orthoptist b. All other ocular structures must be within normal limits (including visual acuity).~  7. Group 3:~ 1. No evidence of reading disability, attention deficit disorder or ocular anomaly, including eye muscle or movement disorder as specified above.~     Exclusion Criteria:~* 1. Myopia more than - 6.00 diopters (spherical equivalent) in either eye. 2. Hyperopia more than + 6.00 diopters (spherical equivalent) in either eye. 3. History of vision therapy or orthoptic treatment 4. Any ocular anomaly with the exception of eye movement disorder for group 2.

- Gender: ALL
- Minimum Age: 7 Years
- Maximum Age: 13 Years
- Healthy Volunteers: t

Study Arms:
- Children with reading disabilities (Type: None): Children diagnosed with reading disabilities (age 7 to 13).
- Children with eye movement disorders (Type: None): Children diagnosed with eye movement disorders (age 7 to 13).
- Control Group (Type: None): Children with normal reading ability and normal eye movements (age 7 to 13.

Based on this trial design, predict the completion outcome and termination type (if applicable).